Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald E Mager

Showing results (51-60 of 163) with videos related to

Pageof 17
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 26, 2012
Mechanism-based pharmacodynamic modelingMelanie A Felmlee, Marilyn E Morris, Donald E Mager
Journal of Pharmaceutical Sciences|March 28, 2003
Integrated QSPR--pharmacodynamic model of genomic effects of several corticosteroidsDonald E Mager, Nancy A Pyszczynski, William J Jusko
Journal of Pharmacokinetics and Pharmacodynamics|November 1, 2022
Accelerating robust plausible virtual patient cohort generation by substituting ODE simulations with parameter space mappingThibaud Derippe, Sylvain Fouliard, Xavier Declèves, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 15, 2024
Quantitative systems pharmacology modeling of tumor heterogeneity in response to BH3-mimetics using virtual tumors calibrated with cell viability assaysThibaud Derippe, Sylvain Fouliard, Xavier Decleves, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 12, 2010
Role of p-glycoprotein in region-specific gastrointestinal absorption of talinolol in ratsLeonid Kagan, Tali Dreifinger, Donald E Mager, et al.
Journal of Clinical Pharmacology|May 26, 2017
Model-Based Evaluation of Exenatide Effects on the QT Interval in Healthy Subjects Following Continuous IV InfusionBrenda Cirincione, Frank LaCreta, Philip Sager, et al.
Mabs|September 24, 2016
Systems pharmacology and enhanced pharmacodynamic models for understanding antibody-based drug action and toxicitySihem Ait-Oudhia, Meric Ayse Ovacik, Donald E Mager
The AAPS Journal|August 2, 2013
Population pharmacodynamic modeling of hyperglycemic clamp and meal tolerance tests in patients with type 2 diabetes mellitusYing Hong, Jasper Dingemanse, Patricia Sidharta, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 12, 2023
Comparison of sequential and joint nonlinear mixed effects modeling of tumor kinetics and survival following Durvalumab treatment in patients with metastatic urothelial carcinomaTing Chen, Yanan Zheng, Lorin Roskos, et al.
Pharmaceutics|March 21, 2014
Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncologySihem Ait-Oudhia, Donald E Mager, Robert M Straubinger
Pageof 17

Showing results (51-60 of 163) with videos related to

Sort By:
Pageof 17
Methods in Molecular Biology (Clifton, N.J.)|September 26, 2012
Mechanism-based pharmacodynamic modelingMelanie A Felmlee, Marilyn E Morris, Donald E Mager
Journal of Pharmaceutical Sciences|March 28, 2003
Integrated QSPR--pharmacodynamic model of genomic effects of several corticosteroidsDonald E Mager, Nancy A Pyszczynski, William J Jusko
Journal of Pharmacokinetics and Pharmacodynamics|November 1, 2022
Accelerating robust plausible virtual patient cohort generation by substituting ODE simulations with parameter space mappingThibaud Derippe, Sylvain Fouliard, Xavier Declèves, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 15, 2024
Quantitative systems pharmacology modeling of tumor heterogeneity in response to BH3-mimetics using virtual tumors calibrated with cell viability assaysThibaud Derippe, Sylvain Fouliard, Xavier Decleves, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 12, 2010
Role of p-glycoprotein in region-specific gastrointestinal absorption of talinolol in ratsLeonid Kagan, Tali Dreifinger, Donald E Mager, et al.
Journal of Clinical Pharmacology|May 26, 2017
Model-Based Evaluation of Exenatide Effects on the QT Interval in Healthy Subjects Following Continuous IV InfusionBrenda Cirincione, Frank LaCreta, Philip Sager, et al.
Mabs|September 24, 2016
Systems pharmacology and enhanced pharmacodynamic models for understanding antibody-based drug action and toxicitySihem Ait-Oudhia, Meric Ayse Ovacik, Donald E Mager
The AAPS Journal|August 2, 2013
Population pharmacodynamic modeling of hyperglycemic clamp and meal tolerance tests in patients with type 2 diabetes mellitusYing Hong, Jasper Dingemanse, Patricia Sidharta, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 12, 2023
Comparison of sequential and joint nonlinear mixed effects modeling of tumor kinetics and survival following Durvalumab treatment in patients with metastatic urothelial carcinomaTing Chen, Yanan Zheng, Lorin Roskos, et al.
Pharmaceutics|March 21, 2014
Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncologySihem Ait-Oudhia, Donald E Mager, Robert M Straubinger
Pageof 17